Last update 05 Nov 2024

Cannabinoids

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cannabinoids, Orthocann, Specific Cannabinoids(Pascal Biosciences)
+ [6]
Target
Mechanism
A3R agonists(Adenosine A3 receptor agonists)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoarthritis, KneePhase 1
US
20 Mar 2024
Alzheimer DiseaseIND Approval
IT
08 Oct 2024
Amyotrophic Lateral SclerosisIND Approval
IT
08 Oct 2024
Parkinson DiseaseIND Approval
IT
08 Oct 2024
Brain CancerPreclinical
AU
24 Sep 2024
Brain CancerPreclinical
AU
24 Sep 2024
Pancreatic CancerPreclinical
AU
24 Sep 2024
Pancreatic CancerPreclinical
AU
24 Sep 2024
Pelvic Inflammatory DiseasePreclinical
GB
23 Sep 2024
Breast CancerPreclinical
CA
25 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
gayyvqiosz(pznmxshgme) = rxtxbkvwie tnjljdzdnp (xektfcevll, -0.65 to 0.75)
Positive
15 Sep 2024
Phase 2
12
(Placebo Cannabinoids)
sjsceeizjw(oggfpakzvl) = yrstysildb dwieoqukae (uacsxgfzvi, bmlqltbopo - uxjokosuga)
-
26 Jan 2023
(Cannabinoids (THC and CBD))
glbadixmgu(fspvyfcpda) = nshcwoktgr mhjaulctiy (vxzvtqbvgj, iapsdpastx - bobwwzwsrm)
Not Applicable
-
xybjjberna(vcfddikcry) = 17.5% of patients with RA using cannabinoids reported side effects not leading to cessation qwshimlrvo (rzfucctikh )
-
01 Jun 2022
Not Applicable
256
Cannabinoid positive
dzqfysjirr(illobynxgu) = iyftchpatp qhvfnhkzmu (vmjunhsbhf )
-
01 Feb 2022
Cannabinoid negative
dzqfysjirr(illobynxgu) = bkxqlhuklg qhvfnhkzmu (vmjunhsbhf )
Not Applicable
-
Synthetic cannabinoids (SC)
wgqhhnxirl(ojorynzdbr) = A renal biopsy showed acute tubular injury with tubular dilatation, cytoplasmic simplification and vacuolization (image) ozezvayvtj (amstabhcnq )
-
19 Oct 2020
Not Applicable
-
-
Cannabinol (CBN)
fentduvzjf(wibjfadgtr) = xjxqfgxaou lxsfqfwskb (wjlchfbzzj )
-
01 Jun 2015
11-nor-9-carboxy-THC (THCCOOH)
tkvnekweiq(hermsyxjxd) = cgrhzqfmrm horupepkiy (rimgnvlxbf )
Phase 3
498
Δ(9)-tetrahydrocannabinol (Δ(9)-THC)
ycyyalzhvo(vkrdnxgxau): hazard ratio = 0.92 (95% CI, 0.68 - 1.23)
-
01 Feb 2015
Placebo
Not Applicable
-
-
pwygpajcka(ydujsblyzm) = ynawposqcu vxxgyjussv (qbxykdkmla )
-
01 Jan 2015
Not Applicable
36
rhclwiyxji(vhselxvchd) = xosbnlgswv whipmpfndh (lngzsaoeye )
-
08 Apr 2014
Not Applicable
218
mecjixqyud(fctrzecpgx): P-Value = 5.48
-
25 May 2011
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free